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Abstract 
 
Independent monitor unit (MU) calculations are a vital part of radiotherapy treatment 
planning quality assurance. In the case of complex treatment planning methods, such as 
intensity modulated radiotherapy (IMRT), traditional independent monitor unit 
calculations using tables of beam data and manual calculations are inadequate. 
Recently, computer programs have been developed that can perform independent 
monitor unit calculations for IMRT treatment plans using scatter summation methods. 
One such program is RadCalc, produced by Lifeline Software Inc. The purpose of this 
project was to test RadCalc, and determine whether it is suitable for routine use in 
IMRT treatment planning quality assurance. 
 
Once the software was installed, beam data measured on the treatment linear accelerator 
(linac) was imported into RadCalc, to be used in MU calculations. RadCalc was tested 
for data integrity to ensure that the correct data was accessed for its calculations. The 
interface between RadCalc and the treatment planning system, Pinnacle3, was set up so 
that treatment plan data could be imported directly from Pinnacle3 into RadCalc. Test 
plans were imported into RadCalc to ensure the Pinnacle3-RadCalc interface was 
working correctly. 
 
Test plans were created with open, blocked, segmented and IMRT fields, and delivered 
to a phantom on the linac to test RadCalc’s block correction algorithm. Doses were 
measured using a thimble ionisation chamber, and compared to the doses calculated by 
RadCalc and Pinnacle3. The agreement between RadCalc and measured doses for most 
situations was comparable to the agreement between Pinnacle3 and measured doses. 
However, a systematic difference between RadCalc and measured dose was shown to 
occur for asymmetric fields. In addition to this, an increase in the level of blocking of 
the calculation point for segmented and IMRT fields appeared to increase the difference 
between RadCalc and measured dose. 
 
Thirty-two patient IMRT plans at the Illawarra Cancer Care Centre (ICCC) were 
verified by reproducing the plan using a phantom CT dataset, and then delivering the 
fields to the phantom and measuring the delivered dose. This data was compared to the 
doses calculated by RadCalc and Pinnacle3. The doses calculated by RadCalc and 
 xx 
Pinnacle3 for the plans created on patient CT datasets were also compared. In analysing 
the data, a systematic difference between RadCalc and measured dose was detected. 
Improved agreement was achieved by adjusting the MLC transmission parameter in 
RadCalc. The average percentage difference per field for the phantom plans between 
RadCalc and measured dose was 0.1% with a standard deviation 5.3%, while the 
average percentage difference between Pinnacle3 and measured dose was -0.2% with a 
standard deviation of 4.2%. The average percentage difference for total plan dose for 
the phantom plans between RadCalc and measured dose was 0.0% with a standard 
deviation 1.7%, while the average percentage difference between Pinnacle3 and 
measured dose was -0.3% with a standard deviation of 1.1%. For the patient plans, the 
average percentage difference per field between RadCalc and Pinnacle3 was 0.8% with 
a standard deviation of 5.6%, while the average percentage difference per plan was 
1.1% with a standard deviation of 1.1%.  
 
The final recommendation is that RadCalc is accurate enough for routine IMRT 
treatment planning quality assurance. A physical measurement should accompany the 
RadCalc check to verify the transfer of data to the record and verify system and the dose 
delivery process. 
 
